Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 8 Parkinson's papers of 1,184 | 0.71 |
| pathways Reactome | 3 pathways; mostly growth signalling | 0.60 |
No case: the score is under the bar. Receipt 4205
Sealed predictions
- SEMA3A in dopamine neurons, braak+0.43 (p 0.244) → +0.45 (p 0.219)receipt 4212
Swarm cases
receipt 4212: SEMA3A in dopamine neurons, braak
- power
- full sample +0.46 (p 0.057, n 18), 95% CI -0.01 to +0.76. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.46 (p 0.054, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.53 (p 0.023, n 18). not the mix.
- skeptic
- leave-one-out range +0.38 to +0.63, sign flips 0; without severely affected donors +0.46 (p 0.057, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SEMA3A in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts